NSE: TRANSPEK · BSE: 506687 · ISIN INE687A01016
Transpek Industry Limited stock analysis
Transpek Industry Limited ranks #3905 in the TickerSutra evidence-ranked universe with a score of 37/100 and 95% data confidence. The latest captured fundamentals show ROCE of 8.4%, quarterly sales growth of -2.1% and quarterly profit growth of -42.7%.Avoid / exit review
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- Low debt/equity of 0.1×
- Strong CFO/EBITDA of 0.83×
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- No calculated threshold risk in the current snapshot.
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹599cr | ₹100cr | ₹65cr | 17.0% |
| 2023 | ₹827cr | ₹151cr | ₹83cr | 18.0% |
| 2024 | ₹580cr | ₹82cr | ₹39cr | 14.0% |
| 2025 | ₹650cr | ₹103cr | ₹49cr | 16.0% |
| 2026 | ₹621cr | ₹94cr | ₹46cr | 15.0% |
| TTM | ₹618cr | ₹89cr | ₹39cr | 14.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
MANAGEMENT COMMENTARY
Signals from filed documents
Now, coming to our financial performance, as I mentioned earlier, growth across the chemical industry has remained soft and Transpek has not been an exception. Against the backdrop of Transpek Industry Limited August 20, 2026 Page 6 of 26 aggressive pricing, oversupply, and subdued demand in export markets, your company has delivered a steady performance. Total revenue for Q1 FY ‘27 stood at INR155.1 crores, while th
At the same time, the growing preference among global customers for diversified sourcing and reduced dependence on single geographies is creating opportunities for Indian chemical manufacturers with strong compliance standards and operational capabilities. Our business, however, continued to operate in a challenging environment with pricing pressures from Indian and global competitors impacting the industry. Despite
Supported by a healthy balance sheet, the organisation is accelerating its growth blueprint, which includes scaling ventures outside its historical acid chloride stronghold. Recognising that the existing facility faces physical constraints due to regulatory environmental caps, management is rigorously assessing various avenues to acquire the necessary production infrastructure to accommodate future scale. Material de
Company is also looking to, or considering to add another manufacturing site, for which options are being explored. The company has recently expressed interest in acquisition of land in Odisha in a notified zone which has been approved by the Odisha government. Now, they are asking us to give a detailed feasibility report which we are preparing.
Sir, so, and this investment was increasing in value, but in the past 2 years the value is actually declining, and even the dividend that we have received from there, that has also declined marginally, sir. So, sir, since we are now embarking on a greenfield capex in Odisha, or at least we are planning, sir, so if unless this investment was increasing, there was no problem in holding, but now if it is not increasing
Market Stance: The Company successfully defended and, in some areas, expanded its footprint in key markets. Amidst a rigorous sector-wide environment, the Company exhibited notable fortitude, driven by: Technological Optimisation Circular Operations Relentless margin pressures are compelling the industry to aggressively pursue operational leanness through Industry 4.0 innovations. Transpek has proactively commenced t
I will have to maintain my market share, whatever I have captured at 20%. At 11% or so, I have to maintain and wait for the right opportunity again to get back into that higher margin level. I don't want to name any other company in this call, but if individually we meet, I will tell you.
Our medium and long-term strategy, I already spoke about some of the products, so it's same, is focused on polymers, monomers, additives, enhancers, multistep sulfonation products, electronics and battery chemicals, and chloro-fluoro intermediates. In all of this, the focus is on value-added complex products. Company is also looking to, or considering to add another manufacturing site, for which options are being exp
And once permissions come, then naturally the construction work will start. So definitely it cannot be a 1-year job where you will see commercial production within 1 year. It should be at least 1.5 to 2 years.
The facility of participation at the AGM through VC/OAVM will be made available to at least 1000 members on first come first served basis. This will not include large shareholders (shareholders holding 2% or more shareholding), Promoters, Institutional Investors, Directors, Key Managerial Personnel, the Chairpersons of the Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee,
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…